Browsing by Author "Yalcin, Arzu Didem"

Now showing items 1-3 of 3

IL8 and Serum Soluble TRAIL Levels Following Anti-VEGF Monoclonal Antibody Treatment in Patients with Metastatic Colon Cancer

Kargi, Aysegul; Yalcin, Arzu Didem; Erin, Nuray; Savas, Burhan; Polat, H. Huseyin; Gorczynski, Reginald M. (CLIN LAB PUBL, 2012)

Background: Colorectal cancer is the third most common human cancer and the third leading cause of cancer related death. BevacizumAb is a humanized monoclonal antibody developed against vascular endothelial growth factor ...
IL8 and Serum Soluble TRAIL Levels Following Anti-VEGF Monoclonal Antibody Treatment in Patients with Metastatic Colon Cancer (vol 58, pg 501, 2012)

Kargi, Aysegul; Yalcin, Arzu Didem; Erin, Nuray; Savas, Burhan; Polat, H. Huseyin; Gorczynski, Reginald M. (CLIN LAB PUBL, 2012)

Background: Colorectal cancer is the third most common human cancer and the third leading cause of cancer related death. BevacizumAb is a humanized monoclonal antibody developed against vascular endothelial growth factor ...
Pollen aero allergens and the climate in mediterranean region and allergen sensitivity in allergic rhinoconjunctivitis and allergic asthma patients

Yalcin, Arzu Didem; Basaran, Saime; Bisgin, Atil; Polat, Hasan Huseyin; Gorczynski, Reginald M. (INT SCIENTIFIC LITERATURE, INC, 2013)

Background: We evaluated the profiles of allergic rhino-conjunctivitis and asthma patients annually in Antalya, a Mediterranean coastal city in Turkey. Material/Methods: We evaluated patients' allergic clinical status, and ...